Sonic Healthcare (SHL) Profit Report - FY15 result in line with July 2015 earnings update

Bell Potter


Sonic Healthcare's organic revenue growth was ~5%, enhanced by accretive acquisitions. Australian Laboratory revenue growth of 5% included 0.5% relating to the SAN Pathology acquisition was completed in December 2014. Fees and volumes were negatively impacted by Medicare changes from 1 November 2014. Net operating cashflow was down 8% to $512m. Read our full summary here: (VIEW LINK)

1 topic

1 stock mentioned

Bell Potter Securities is a leading Australian stockbroking, investment and financial advisory firm that provides a comprehensive offering of financial services to a diversified client base that includes individuals, institutions and corporations.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.